Lung cancer is the leading cause of cancer death globally. Although molecularly targeted agents have made small advances in the treatment options for patients, the overall 5-year survival rate has changed little in the past several decades, necessitating a greater understanding of the biology driving tumor progression and metastasis. MicroRNAs (miRNAs) are a relatively recently discovered class of non-protein coding RNAs that modulate extremely important cellular functions via their post-Transcriptional regulation of mRNAs. Recent evidence from multiple tumor types and model systems implicates miRNA dysregulation as a common mechanism of tumorigenesis and progression. This represents a rapidly emerging and changing field with new biological connections and applications being reported each month, which provide unique insights into miRNA functions and potential new approaches for diagnosis and therapy. © 2011 Springer Science+Business Media B.V.
CITATION STYLE
Gibbons, D. L., Rizvi, Z. H., & Kurie, J. M. (2011). The role of MicroRNAs in lung cancer development, progression, and metastasis. In MicroRNAs in Cancer Translational Research (pp. 73–89). Springer Netherlands. https://doi.org/10.1007/978-94-007-0298-1_2
Mendeley helps you to discover research relevant for your work.